chr16-8859225-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014316.4(CARHSP1):c.104G>A(p.Arg35Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000981 in 1,601,130 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 26)
Exomes 𝑓: 0.000099 ( 0 hom. )
Consequence
CARHSP1
NM_014316.4 missense
NM_014316.4 missense
Scores
3
2
6
Clinical Significance
Conservation
PhyloP100: 4.67
Genes affected
CARHSP1 (HGNC:17150): (calcium regulated heat stable protein 1) Enables mRNA 3'-UTR binding activity. Predicted to be involved in regulation of mRNA stability. Predicted to be located in P granule and cytosol. Predicted to be active in cytoplasm. Predicted to colocalize with cytoplasmic exosome (RNase complex). [provided by Alliance of Genome Resources, Apr 2022]
PMM2 (HGNC:9115): (phosphomannomutase 2) The protein encoded by this gene catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate, which is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in this gene have been shown to cause defects in glycoprotein biosynthesis, which manifests as carbohydrate-deficient glycoprotein syndrome type I. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CARHSP1 | NM_014316.4 | c.104G>A | p.Arg35Gln | missense_variant | 2/4 | ENST00000311052.10 | |
LOC100130283 | NR_147908.1 | n.635-903C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CARHSP1 | ENST00000311052.10 | c.104G>A | p.Arg35Gln | missense_variant | 2/4 | 1 | NM_014316.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000845 AC: 12AN: 141950Hom.: 0 Cov.: 26
GnomAD3 genomes
AF:
AC:
12
AN:
141950
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000528 AC: 13AN: 245980Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133808
GnomAD3 exomes
AF:
AC:
13
AN:
245980
Hom.:
AF XY:
AC XY:
6
AN XY:
133808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000994 AC: 145AN: 1459180Hom.: 0 Cov.: 34 AF XY: 0.0000950 AC XY: 69AN XY: 725972
GnomAD4 exome
AF:
AC:
145
AN:
1459180
Hom.:
Cov.:
34
AF XY:
AC XY:
69
AN XY:
725972
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000845 AC: 12AN: 141950Hom.: 0 Cov.: 26 AF XY: 0.0000588 AC XY: 4AN XY: 68082
GnomAD4 genome
AF:
AC:
12
AN:
141950
Hom.:
Cov.:
26
AF XY:
AC XY:
4
AN XY:
68082
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 28, 2023 | The c.104G>A (p.R35Q) alteration is located in exon 2 (coding exon 1) of the CARHSP1 gene. This alteration results from a G to A substitution at nucleotide position 104, causing the arginine (R) at amino acid position 35 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Pathogenic
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Uncertain
T
MutationTaster
Benign
D;D;D;D;D
PROVEAN
Pathogenic
D
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at